Actively Recruiting
Active Removal of IntraCerebral Hematoma Via Active Irrigation
Led by IRRAS · Updated on 2024-08-01
60
Participants Needed
1
Research Sites
201 weeks
Total Duration
On this page
Sponsors
I
IRRAS
Lead Sponsor
U
University of Helsinki
Collaborating Sponsor
AI-Summary
What this Trial Is About
Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular hemorrhage compared with passive drainage.
CONDITIONS
Official Title
Active Removal of IntraCerebral Hematoma Via Active Irrigation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Need for external ventricular drainage (EVD)
- Receiving active treatment
- Signed informed consent obtained according to institutional and country laws
- Spontaneous intracerebral hemorrhage measuring up to 30 square centimeters
- Normal coagulation profile if needed (PT, PTT, platelet count)
- Treatment initiated within 72 hours of bleeding onset
- Ability to receive 2.0 mg of tPA daily for 3 days
You will not qualify if you...
- Age under 18 years
- No need for external ventricular drainage (EVD)
- Fixed and dilated pupils
- Uncorrectable coagulopathy
- Vascular pathology such as aneurysm or arteriovenous malformation involvement
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Helsinki University
Helsinki, Finland
Actively Recruiting
Research Team
J
John Unser, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here